Brentuximab vedotin with chemotherapy for stage 3/4 classical Hodgkin lymphoma: three-year update of the ECHELON-1 study
Straus, DJ Dlugosz-Danecka, M Alekseev, S Illes, A Picardi, M Lech-Maranda, E Feldman, T Savage, KJ Smolewski, P Bartlett, NL
Straus, DJ
Dlugosz-Danecka, M
Alekseev, S
Illes, A
Picardi, M
Lech-Maranda, E
Feldman, T
Savage, KJ
Smolewski, P
Bartlett, NL
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Straus D, Dlugosz-Danecka M, Alekseev S, Illes A, Picardi M, Lech-Maranda E, et al. Brentuximab vedotin with chemotherapy for stage 3/4 classical Hodgkin lymphoma: three-year update of the ECHELON-1 study. J Clin Oncol. 2019;37(15).